Studies have confirmed that IL-6 and its expression are associated with insulin resistance and β-cell dysfunction, diabetic retinopathy and obstructive sleep apnea hypopnea syndrome (OSAHS) in T2DM [13–15]. Here, IL6 is linked to type 2 diabetes mellitus.